Endovascular treatment of dural arteriovenous shunts

Ali Shaibani; Richard Parkinson; Eric J. Russell; Bernard R. Bendok; Richard A. Bernstein; Matthew Walker; Ajay K. Wakhloo

doi:10.1053/j.scds.2005.01.004

Endovascular treatment of dural arteriovenous shunts

Ali Shaibani, Richard Parkinson, Eric J. Russell, Bernard R. Bendok, Richard A. Bernstein, Matthew Walker, Ajay K. Wakhloo

Neurologic Surgery

Research output: Contribution to journal › Article › peer-review

Abstract

Dural arteriovenous shunts comprise 10% to 15% of intracranial vascular malformations. Their pathophysiology is complex and their natural history has only recently been adequately elucidated. High-grade dural arteriovenous shunts (those with cortical venous reflux) are associated with a 6.9% annual incidence of nonhemorrhagic neurologic complications, a 8.1% annual incidence of intracranial hemorrhage, and a 10.1% annual mortality rate. This article provides an overview of the imaging, workup, and indications and latest techniques for endovascular treatment of dural arteriovenous shunts. Treatment efficacy and complication rates are also discussed.

Original language	English (US)
Pages (from-to)	176-194
Number of pages	19
Journal	Seminars in Cerebrovascular Diseases and Stroke
Volume	4
Issue number	4
DOIs	https://doi.org/10.1053/j.scds.2005.01.004
State	Published - Dec 2004

Keywords

Dural
Embolization
Endovascular
Fistula
Natural history

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1053/j.scds.2005.01.004

Cite this

@article{5135f191a4894862b3f312aa24adcc37,

title = "Endovascular treatment of dural arteriovenous shunts",

abstract = "Dural arteriovenous shunts comprise 10% to 15% of intracranial vascular malformations. Their pathophysiology is complex and their natural history has only recently been adequately elucidated. High-grade dural arteriovenous shunts (those with cortical venous reflux) are associated with a 6.9% annual incidence of nonhemorrhagic neurologic complications, a 8.1% annual incidence of intracranial hemorrhage, and a 10.1% annual mortality rate. This article provides an overview of the imaging, workup, and indications and latest techniques for endovascular treatment of dural arteriovenous shunts. Treatment efficacy and complication rates are also discussed.",

keywords = "Dural, Embolization, Endovascular, Fistula, Natural history",

author = "Ali Shaibani and Richard Parkinson and Russell, {Eric J.} and Bendok, {Bernard R.} and Bernstein, {Richard A.} and Matthew Walker and Wakhloo, {Ajay K.}",

year = "2004",

month = dec,

doi = "10.1053/j.scds.2005.01.004",

language = "English (US)",

volume = "4",

pages = "176--194",

journal = "Seminars in Cerebrovascular Diseases and Stroke",

issn = "1528-9931",

publisher = "W.B. Saunders Ltd",

number = "4",

}

TY - JOUR

T1 - Endovascular treatment of dural arteriovenous shunts

AU - Shaibani, Ali

AU - Parkinson, Richard

AU - Russell, Eric J.

AU - Bendok, Bernard R.

AU - Bernstein, Richard A.

AU - Walker, Matthew

AU - Wakhloo, Ajay K.

PY - 2004/12

Y1 - 2004/12

N2 - Dural arteriovenous shunts comprise 10% to 15% of intracranial vascular malformations. Their pathophysiology is complex and their natural history has only recently been adequately elucidated. High-grade dural arteriovenous shunts (those with cortical venous reflux) are associated with a 6.9% annual incidence of nonhemorrhagic neurologic complications, a 8.1% annual incidence of intracranial hemorrhage, and a 10.1% annual mortality rate. This article provides an overview of the imaging, workup, and indications and latest techniques for endovascular treatment of dural arteriovenous shunts. Treatment efficacy and complication rates are also discussed.

AB - Dural arteriovenous shunts comprise 10% to 15% of intracranial vascular malformations. Their pathophysiology is complex and their natural history has only recently been adequately elucidated. High-grade dural arteriovenous shunts (those with cortical venous reflux) are associated with a 6.9% annual incidence of nonhemorrhagic neurologic complications, a 8.1% annual incidence of intracranial hemorrhage, and a 10.1% annual mortality rate. This article provides an overview of the imaging, workup, and indications and latest techniques for endovascular treatment of dural arteriovenous shunts. Treatment efficacy and complication rates are also discussed.

KW - Dural

KW - Embolization

KW - Endovascular

KW - Fistula

KW - Natural history

UR - http://www.scopus.com/inward/record.url?scp=24344485449&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=24344485449&partnerID=8YFLogxK

U2 - 10.1053/j.scds.2005.01.004

DO - 10.1053/j.scds.2005.01.004

M3 - Article

AN - SCOPUS:24344485449

SN - 1528-9931

VL - 4

SP - 176

EP - 194

JO - Seminars in Cerebrovascular Diseases and Stroke

JF - Seminars in Cerebrovascular Diseases and Stroke

IS - 4

ER -

Endovascular treatment of dural arteriovenous shunts

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this